Total: $88.35M

Year to Date: $127.63M

Company (Symbol)#*

Partner (Country)

Amt. (M)

Details (Date)

Addex Pharmaceuticals Ltd. (Geneva)

Ortho-McNeil-Janssen Pharmaceuticals Inc. (unit of Johnson & Johnson; New Brunswick, N.J.)

$2.8

For the start of a Phase IIa trial of ADX71149 in schizophrenia (3/29)

Aeterna Zentaris Inc. (Quebec City)

Cowen Healthcare Royalty Partners LP

$2.5

For 2010 net sales of the fertility drug Cetrotide reaching a specified level (3/1)

Affiris AG (Vienna, Austria)

GlaxoSmithKline Biologicals (London)

€2.5 ($3.4)

For the exercise of an option for the alternative vaccine candidates against Alzheimer's disease generated using the AFFITOME technology (3/1)

BioInvent International AB (Lund, Sweden)

Genentech Inc. (South San Francisco)

$15

For dosing the first patient in a Phase II study of BI-204 in stable atherosclerotic cardiovascular disease (3/15)

FibroGen Inc. (San Francisco)

Astellas Pharma Inc. (Tokyo)

$40

For the start of Phase IIb testing of FG-4592 in anemia in chronic kidney disease patients both on dialysis and not on dialysis (3/18)

GW Pharmaceuticals plc (Porton Down, UK)

Almirall SA (Barcelona, Spain)

£2.5 ($4)

For the launch of cannabis-derived drug Sativex in Spain (3/16)

Innate Pharma SA (Marseilles, France)

Novo Nordisk A/S (Bagsvaerd, Denmark)

ND

For the filing of a European trial application for IPH2201, a humanized antibody that targets chronic inflammatory and autoimmune diseases (3/1)

MediGene AG (Martinsried, Germany)

Astellas Pharma Europe Ltd. (London)

€15 ($20.65)

For the transfer of exclusive European rights to Eligard for the treatment of hormone-dependent prostate cancer (3/2)

NPS Pharmaceuticals Inc. (Bedminster, N.J.)

Nycomed GmbH (Zurich, Switzerland)

ND

For the European marketing authorization for teduglutide as a treatment for short bowel syndrome (3/29)

Notes:

Currency conversions are based on exchange rates at the time of the deal.

The date indicated refers to the BioWorld Today issue in which the news item can be found.

ND = Not disclosed. ** Denotes the date the item ran in BioWorld International.